Increased expression of TFCP2L1 as a result of blocking CXCR2 activity in mouse models of melanoma resulted in decreased expression of genes involved in tumor growth and increased expression of genes associated with tumor suppression [170]. The gene discussed is TFCP2L1; the disease is melanoma.